These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 16891860

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A phase II trial of the combination of gemcitabine, ifosfamide and cisplatin in the treatment of advanced non-small cell lung cancer.
    Vadell-Nadal C, Nogué-Aliguer M, Fabregat-Mayol X, Saigí-Grau E, Gallén-Castillo M.
    Lung Cancer; 2000 May; 28(2):109-15. PubMed ID: 10717328
    [Abstract] [Full Text] [Related]

  • 26. Analysis of long-term survivors after platinum containing chemotherapy in advanced non-small cell lung cancer.
    Satoh H, Ishikawa H, Yamashita YT, Naito T, Takahashi H, Kamma H, Ohtsuka M, Hasegawa S.
    Anticancer Res; 1998 May; 18(2B):1295-8. PubMed ID: 9615805
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial.
    Loehrer PJ, Jiroutek M, Aisner S, Aisner J, Green M, Thomas CR, Livingston R, Johnson DH.
    Cancer; 2001 Jun 01; 91(11):2010-5. PubMed ID: 11391579
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Triplet chemotherapy combination with gemcitabine, cisplatin and ifosfamide in patients with advanced non-small-cell lung cancer: phase II study.
    Mohedano Mohedano N, Sánchez Rovira P, Lozano Barriuso A, Fernandez Morales M, Medina Magan B, Jaen Morago A, Porras Quintela I, Dueñas Garcia R, Fernandez Flores E, Moreno Moreno MA.
    Am J Clin Oncol; 2003 Aug 01; 26(4):363-5. PubMed ID: 12902886
    [Abstract] [Full Text] [Related]

  • 32. [Comparison of NP and MVP regimen in treatment of advanced non-small cell lung cancer].
    Qiang E, Wang SP, Liu SJ, Yiao J.
    Ai Zheng; 2002 Dec 01; 21(12):1362-4. PubMed ID: 12520749
    [Abstract] [Full Text] [Related]

  • 33. Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study.
    Sutton G, Kauderer J, Carson LF, Lentz SS, Whitney CW, Gallion H, Gynecologic Oncology Group.
    Gynecol Oncol; 2005 Mar 01; 96(3):630-4. PubMed ID: 15721404
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma.
    Kosmas C, Tsavaris NB, Polyzos A, Kalofonos HP, Sepsas E, Malamos NA, Vadiaka M, Dosios T, Antonopoulos MJ.
    Cancer; 2000 Aug 15; 89(4):774-82. PubMed ID: 10951340
    [Abstract] [Full Text] [Related]

  • 37. Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer.
    Chen YM, Perng RP, Whang-Peng J, Wu HW, Lin WC, Tsai CM.
    Lung Cancer; 2000 Dec 15; 30(3):199-202. PubMed ID: 11137205
    [Abstract] [Full Text] [Related]

  • 38. The treatment of advanced non-small-cell lung cancer (NSCLC)--overseas updated and local experiences.
    Chu DT, Zhang XR, Li JL, Qu FL, Sun Y.
    Gan To Kagaku Ryoho; 2002 Feb 15; 29 Suppl 1():117-24. PubMed ID: 11890097
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.